chlorambucil has been researched along with mitoxantrone in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (16.28) | 18.2507 |
| 2000's | 24 (55.81) | 29.6817 |
| 2010's | 9 (20.93) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Flanagan, JU; Kemp, CA; Maréchal, JD; Paine, MJ; Roberts, GC; Sutcliffe, MJ; van Eldik, AJ; Wolf, CR | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Burckhardt, G; Flörl, S; Hagos, Y; Kühne, A; Marada, VV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Green, JA; Watkin, SW | 1 |
| Burghouts, JT | 1 |
| Gouyette, A | 1 |
| Bernard, T; Johnson, SA; Jones, L; Newland, AC; Phillips, MJ; Prentice, AG | 1 |
| Gerrits, WB; Haak, HL; Kerkhofs, H; Wijermans, PW | 1 |
| Gerweck, LE; Kozin, SV | 1 |
| Johnson, S; Nicholson, AG; Rule, S; Stone, R; Tighe, M; Tomlinson, J | 1 |
| Advani, S; Chiplunkar, S; Kode, J | 1 |
| Brückner, S; Gerke, P; Roth-Isigkeit, A; Siemens, HJ; Steinhoff, J; Wagner, K | 1 |
| Hussain, BM; Nath, SV; Parekh, BB; Patel, KM; Shah, SA; Vyas, V | 1 |
| Bergmann, M; Busch, R; Emmerich, B; Franke, A; Hallek, M; Hiddemann, W; Hopfinger, G; Pasold, R; Schlag, R; Schmitt, B; Wendtner, CM | 1 |
| Dölken, G; Fiedler, F; Franke, A; Freund, M; Helbig, W; Herold, M; Pasold, R | 1 |
| Alinari, L; Baccarani, M; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Chott, A; Dirisamer, A; Drach, J; Hejna, M; Püspök, A; Raderer, M; Scheithauer, W; Wöhrer, S | 1 |
| Froehner, M; Haase, M; Hakenberg, OW; Wirth, MP | 1 |
| Amine, B; Benbouazza, K; Guedira, N; Hajjaj-Hassouni, N; Harzy, T; Lazrak, N; Rahmouni, R | 1 |
| Chott, A; Drach, J; Hejna, M; Kaufmann, H; Raderer, M; Wöhrer, S; Zielinski, CC | 1 |
| Adams, DJ; Colvin, OM; Flowers, JL; Rizzieri, DA; Shanks, RH | 1 |
| Robinson, H; Rymes, N | 1 |
| Dreyling, M; Hiddemann, W; Hoster, E; Lengfelder, E; Nickenig, C; Pfreundschuh, M; Reiser, M; Trumper, L; Unterhalt, M; Wandt, H | 1 |
| Dörken, B; Dreyling, M; Forstpointner, R; Freund, M; Ganser, A; Hiddemann, W; Hoster, E; Huber, C; Ludwig, WD; Nickenig, C; Trümper, L; Unterhalt, M | 1 |
| Marcus, R | 1 |
| Al-Ali, KH; Assmann, M; Dölken, G; Franke, A; Freund, M; Haak, U; Haas, A; Herold, M; Höffken, K; Ittel, T; Kettner, E; Klinkenstein, C; Knauf, W; Mey, U; Naumann, R; Neser, S; Neubauer, A; Rohrberg, R; Srock, S; von Grünhagen, U | 1 |
| Assmann, M; Dachselt, K; Dölken, G; Haas, A; Herold, M; Hirt, C; Kiefer, T; Leithäuser, M; Neser, S; Niederwieser, D; Rabkin, CS; Rohrberg, R; Schüler, F; Schwenke, C; Srock, S | 1 |
| Jonathan, F | 1 |
| Buckley Woods, H; Papaioannou, D; Rafia, R; Rathbone, J; Stevens, J; Stevenson, M | 1 |
| Al-Balas, QA; Hassan, MA; Jaradat, SA; Matalkah, AM; Mhaidat, NM; Qandil, AM; Thorne, RT | 1 |
| Herold, M; Hirt, C; Lakner, V; Naumann, R; Rothmann, F; Scholz, CW | 1 |
| Anwar, S; Faizan, M; Khan, S | 1 |
| Budau, L; Burchert, A; Dölken, G; Herold, M; Hirt, C; Jäkel, J; Maschmeyer, G; Moll, R; Neubauer, A; Neubauer, E; Strauch, K; Wilhelm, C | 1 |
| Bishton, MJ; Clifton-Hadley, L; Haynes, A; Lush, R; McMillan, A; Patmore, R; Rule, S; Turner, D; Wilson, W | 1 |
| Banavali, S; Gujral, S; Myint, HH; Narula, G; Patkar, N; Prasad, M; Subramanian, P; Tandon, S; Tembhare, P | 1 |
| Aupperle-Lellbach, H; Gedon, J; Kehl, A; Schmidt, JM; von Bomhard, W | 1 |
5 review(s) available for chlorambucil and mitoxantrone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Resistance associated with the glutathione system].
Topics: Alkylating Agents; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Resistance, Multiple; Glutathione; Glutathione Transferase; Humans; Melphalan; Mitoxantrone; Nitrosourea Compounds | 1994 |
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chlorambucil; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Forecasting; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Treatment Outcome; Vidarabine; Vincristine | 2002 |
Use of rituximab in patients with follicular lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Follicular; Mitoxantrone; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Rituximab; Vincristine | 2007 |
Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; England; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Models, Economic; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Rituximab; Vincristine; Wales | 2012 |
10 trial(s) available for chlorambucil and mitoxantrone
| Article | Year |
|---|---|
Mitoxantrone, chlorambucil and prednisolone in the treatment of non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Treatment Outcome | 1994 |
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Recurrence; Teniposide; Vincristine | 1993 |
Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Protocols; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Patient Selection; Prednisolone; Prospective Studies; Remission Induction; Rituximab | 2003 |
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell ly
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Germany; Humans; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine | 2006 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Germany; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2007 |
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Recombinant Proteins; Rituximab; Survival Rate; Treatment Outcome | 2007 |
Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Neoplasm, Residual; Neoplastic Cells, Circulating; Polymerase Chain Reaction; Prednisolone; Prognosis; Remission Induction; Rituximab; Survival Analysis; Translocation, Genetic; Treatment Outcome | 2008 |
Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Follow-Up Studies; Humans; Lymphoma, Follicular; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Rituximab | 2015 |
Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Immunotherapy; Killer Cells, Natural; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Retrospective Studies; Rituximab; T-Lymphocytes; Treatment Outcome; Tumor Microenvironment | 2019 |
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dexamethasone; Female; Follow-Up Studies; Genes, bcl-2; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Neoplasm, Residual; Progression-Free Survival; Prospective Studies; Survival Rate; United Kingdom; Vidarabine; Young Adult | 2020 |
28 other study(ies) available for chlorambucil and mitoxantrone
| Article | Year |
|---|---|
Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
Topics: Binding Sites; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Factual; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2015 |
Non-Hodgkin's lymphoma. A four-drug regimen suitable for elderly patients with advanced disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Patient Compliance; Prednisolone; Procarbazine; Prognosis; Remission Induction; Survival Analysis | 1990 |
Mitoxantrone, methotrexate and chlorambucil in metastatic breast cancer, a combination with relatively low subjective toxicity.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Drug Administration Schedule; Female; Humans; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis | 1990 |
Cytotoxicity of weak electrolytes after the adaptation of cells to low pH: role of the transmembrane pH gradient.
Topics: Adaptation, Physiological; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Death; Cell Membrane; Chlorambucil; CHO Cells; Cricetinae; Hydrogen-Ion Concentration; Mitoxantrone | 1998 |
Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Pneumonia; Prednisolone | 1999 |
T-cell receptor gamma and delta gene rearrangements in T-cell acute lymphoblastic leukemia in Indian patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; Female; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunophenotyping; India; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone; Sex Factors; T-Lymphocytes | 2000 |
A prolonged APTT in a patient with a low grade malignant NHL - a case report.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Coagulation Factors; Chlorambucil; Diagnosis, Differential; Factor IX; Female; Humans; Immunocompromised Host; Kidney Transplantation; Liver; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Palliative Care; Partial Thromboplastin Time; Postoperative Complications; Prednisolone; Prothrombin Time; Splenomegaly; Thrombocytopenia; Ultrasonography | 2002 |
Acute lymphocytic leukemia CNS disease presenting as central diabetes insipidus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Chlorambucil; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Humans; Hypothalamus; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Renal Agents; Tomography, X-Ray Computed | 2002 |
Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case Management; Chlorambucil; Cladribine; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunoglobulin M; Male; Middle Aged; Mitoxantrone; Plasmapheresis; Prednisone; Rituximab; Severity of Illness Index; Thalidomide; Vidarabine; Vinblastine; Vincristine; Vinorelbine; Waldenstrom Macroglobulinemia | 2003 |
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Mitoxantrone; Prednisolone; Treatment Outcome | 2003 |
Urinary immunocytology for primary bladder B cell lymphoma.
Topics: Aged; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers; Chlorambucil; Combined Modality Therapy; Cystectomy; Cystitis; Diagnosis, Differential; Fatal Outcome; Female; Humans; Leukocytes; Lymph Node Excision; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mitoxantrone; Neoplastic Stem Cells; Prednisolone; Pyuria; Urinary Bladder Neoplasms; Urine | 2004 |
IgD kappa myeloma: a new case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Hypercalcemia; Immunoglobulin D; Immunoglobulin kappa-Chains; Male; Middle Aged; Mitoxantrone; Multiple Myeloma; Prednisolone; Renal Insufficiency; Treatment Outcome | 2004 |
Effective treatment of indolent non-hodgkin's lymphomas with mitoxantrone, chlorambucil and prednisone.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Prednisolone; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2005 |
Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 3; Caspase 7; Caspases; Cell Cycle; Chlorambucil; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Activation; Flow Cytometry; Gemcitabine; Humans; Irinotecan; Leukemia, Myeloid; Mitoxantrone; Paclitaxel; U937 Cells; Vidarabine | 2005 |
Extranodal mantle cell lymphoma in a prolapsed ileostomy stump.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dexamethasone; Humans; Ileal Neoplasms; Ileostomy; Lymphoma, Mantle-Cell; Male; Mitoxantrone; Recurrence | 2005 |
Clinical investigations in aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednisolone; Prednisone; Rituximab; Vincristine | 2008 |
Methoxyphenylcipro induces antitumor activity in human cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Chlorambucil; Dose-Response Relationship, Drug; HT29 Cells; Humans; MCF-7 Cells; Mitoxantrone; Prednisolone; Procarbazine; Reactive Oxygen Species | 2013 |
Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Chlorambucil; Disease-Free Survival; Female; Hospitals, Pediatric; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neoplasm Staging; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Survival Rate; Treatment Outcome | 2018 |
Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; Cytarabine; Female; Follow-Up Studies; Humans; India; Male; Mitoxantrone; Neoplasm, Residual; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Survival Rate | 2020 |
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006-2019).
Topics: Animals; Carcinoma, Transitional Cell; Chlorambucil; Dog Diseases; Dogs; Female; Male; Meloxicam; Mitoxantrone; Mutation; Prognosis; Proto-Oncogene Proteins B-raf; Retrospective Studies; Urinary Bladder Neoplasms | 2022 |